<DOC>
	<DOCNO>NCT01578174</DOCNO>
	<brief_summary>The investigator examine effect dexmedetomidine management pain uterine artery embolization .</brief_summary>
	<brief_title>The Effect Dexmedetomidine Management Pain After Uterine Artery Embolization</brief_title>
	<detailed_description>Leiomyoma common female reproductive tract tumor . Uterine artery embolization ( UAE ) minimally invasive treatment alternative hysterectomy myomectomy . However , post-procedural pain control UAE remain major problem . Therefore , aim study evaluate efficacy dexmedetomidine pain control UAE .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>age ≥ 20 , ASA class I II bradycardia ( &lt; 45 bpm ) heart block liver failure renal failure uncontrolled hypertension body mass index ≥ 30 kg/m2</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>